Driving drug safety and therapeutic innovation to improve global health outcomes.
Where Drug Safety Strategy and Technology Converge
Attendees
Speakers
Exhibitors
Tracks
Days
The World Patient Safety Congress Europe is where C-suite, R&D, and Data leaders converge to define the future of patient safety. In addition to examining core areas like benefit-risk management and patient centric approaches, the congress will specifically explore how innovative technologies are transforming safety monitoring. From pharmaceutical drugs, animal health, over the counter drugs to cosmetics and dietary supplements.
Next-generation safety solutions that leverage AI are disruptive forces that can help create a culture and community of innovation, all while improving patient, animal, and consumer safety across all regulated product categories.
The World Patient Safety Congress Europe is where you find the partnerships, technology, and talent to define the future of pharmacovigilance
Driving drug safety and therapeutic innovation to improve global health outcomes.
Shaping the policies and frameworks that ensure patient protection worldwide.
Mitigating clinical and operational hazards through proactive safety strategies.
Ensuring robust pharmacovigilance oversight and continuous benefit-risk monitoring.
Revolutionising safety data processing through cutting-edge intelligent technologies.
Maintaining the highest standards of integrity and adherence to global safety protocols.
Empowering the patient voice to design safer, more inclusive healthcare journeys.
Delivering the specialized tools and services that power the future of patient safety.



























Alex Bica serves as the Head of Early Development at CSL Behring in Marburg, Germany. He is a Fellow of the Royal Society of Public Health in London, United Kingdom, a Fellow of the Academy of Science in Siena, Italy and a Faculty Member at the University of Medicine in Siena. Dr. Bica earned his ...
Rohan has been in Pharmacovigilance for over 15 years across different areas mainly risk management, safety surveillance, aggregate reports, advisory committee meetings, health authority inspections and internal/partner audits. In his most recent role at Regeneron he is leading and supporting cross ...
Dany Ward is an accomplished Executive Director with a proven track record in Pharmacovigilance Operations and Global Risk Management at Jazz Pharmaceuticals. With over 30 years of experience in the pharmaceutical industry, Dany has developed a deep understanding of drug safety regulations and best ...
Im a Pharmacovigilance professional with 18+ years of experience in life-science, out of which 13 spent at established clinical CROs, PV service providers and global pharmaceutical companies. I have experienced with developing and implementing modern PV systems and Safety databases for a variety of ...
Dr. Delphine Saragoussi is Head of Pharmacoepidemiology Vaccines within Patient Safety and Pharmacovigilance at Sanofi, in the greater Paris metropolitan area. She is a physician specialized in public health and social medicine and offers more than 20 years of applied experience in epidemiology and ...
Yvonne Schäfer is a seasoned professional in the field of patient safety and pharmacovigilance, currently serving as the Head of Patient Safety and Pharmacovigilance Systems Business Solutions at Boehringer Ingelheim International. With a strong background in healthcare and pharmaceuticals, Yvonne...
Marie-Laure Kürzinger has more than 25 years of experience in Epidemiology. She started her career in Academia at the University of Medicine - Paris VI, then developed field epidemiology expertise to improve access to healthcare in Burkina Faso and Tanzania. In 2008, she joined Sanofi Pasteur MSD...
Jolanda de Bruijne is Senior Director, Head of Pharmacovigilance Compliance at Teva Pharmaceuticals, with over 25 years of experience in global pharmaceutical regulations and quality systems. She is a recognized expert in regulatory compliance and international pharmacovigilance requirements. She...
Gemma Sayers is a seasoned leader in Pharmacovigilance (PV) Quality, Audit, and Inspection Support with over two decades of experience in the pharmaceutical industry. She currently serves as the Team Lead Quality Auditing, Director at GSK, where she is responsible for developing and delivering the...
Klaudija Marijanovic Barac is a safety physician with over two decades of drug safety leadership in the pharmaceutical industry, building deep expertise across EU GVP requirements, risk management, and health authority interactions. As EU QPPV Deputy at Eli Lilly and Company, she leads PV oversight ...
Maritess Esguerra is a seasoned professional in the field of pharmacovigilance, currently serving as the Senior PV Director at Genentech/Roche. With over 25 years of experience in drug safety and risk management, Maritess has a proven track record of ensuring the safety and well-being of patients...
Mircea Ciuca, MD is a well-known expert in Global Pharmacovigilance, and a constant presence at various PV conferences as keynote speaker, moderator, chairperson etc. He is involved in all aspects of pharmacovigilance, in both development and post-marketing settings, leading various teams of safety ...
I am an academic teaching assistant with a strong background in clinical pharmacy. I work at the Department of Experimental and Clinical Pharmacology at the Medical University of Warsaw, where I teach pharmacology to future healthcare professionals. I am a member of the Polish Society of Clinical...


















































































































































Covering AI & automation, patient centricity, quality assurance, signal management, outsourcing and risk management

100+ leading solution producers to meet your needs across artificial intelligence, quality assurance and signal management to enable operational excellence

Networking is at the heart of World Patient Safety Congress EU. Our congress allows you to connect directly with thousands of thought leaders across 2 days of built-in 1-2-1 networking.



